IMS (Institut du Médicament de Strasbourg)
Preclinical drug development training
- B2B
About IMS (Institut du Médicament de Strasbourg)
Conducting advanced preclinical pharmaceutical research while promoting technological innovation through startup creation and training future researchers in drug development and innovation management.
Key facts
- Industry
- Chemical Manufacturing
- Company size
- 1–10 employees
- Headquarters
- Illkirch-Graffenstaden, Grand Est, France
- Revenue
- $4.2M – $32.5MTamtam estimate
- Website
- ims.unistra.fr
IMS (Institut du Médicament de Strasbourg) at a glance
IMS (Institut du Médicament de Strasbourg) is a B2B company in the Chemical Manufacturing industry, headquartered in Illkirch-Graffenstaden, Grand Est, France.
IMS (Institut du Médicament de Strasbourg) has 1–10 employees.
IMS (Institut du Médicament de Strasbourg)'s revenue is $4.2M – $32.5M (Tamtam estimate).
Selling to companies like IMS (Institut du Médicament de Strasbourg)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies